Mergers and acquisitions deals as a form of business development: evidence from pharmaceutical companies

Published: 10 May 2023| Version 1 | DOI: 10.17632/g3gh9r9px2.1
Contributor:
Daria Medvedeva

Description

Public data on completed M&A and financial performance of companies in the global pharmaceutical industry for the period from 2010 to 2020

Files

Steps to reproduce

You must use Stata econometric package to reproduce the results of the empirical part of the research. For more information about the specification of models, the choice of the optimal model (a model with random effects for H1 and H3, a model with fixed effects for H2), see the text of the research.

Categories

Binary Composite, Financial Analysis, Panel Data Model

Licence